Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication

Hepatology

Volumn 41, Issue 6, 2005, Pages 1349-1356

  Morrissey, David V ^a   Blanchard, Karin ^a   Shaw, Lucinda ^a   Jensen, Kristi ^a   Lockridge, Jennifer A ^a   Dickinson, Brent ^a   McSwiggen, James A ^a   Vargeese, Chandra ^a   Bowman, Keith ^a   Shatter, Chris S ^a   Polisky, Barry A ^a   Zinnen, Shawn ^a  

^a Sirna Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; NUCLEASE; SMALL INTERFERING RNA; VIRUS DNA; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG DOSE REDUCTION; ENZYME DEGRADATION; GENE SILENCING; HEPATITIS B VIRUS; IN VIVO STUDY; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; RNA STABILITY; VIRUS REPLICATION;

ANIMALS; CELL LINE, TUMOR; CONSERVED SEQUENCE; DIMERIZATION; DNA, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG STABILITY; GENE SILENCING; GENE TARGETING; GENOME, VIRAL; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MICE; RNA, SMALL INTERFERING; RNA, VIRAL; VIRUS REPLICATION;

EID: 20044396377     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20702     Document Type: Article

References (20)

1. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-811.
2. Zamore PD. Ancient pathways programmed by small RNAs. Science 2002;296:1265-1269.
3. Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000;404:293-296.
4. Zamore PD, Tuschl T, Sharp PA, Bartel DP. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 2000;101:25-33.
5. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-498.
6. Centers for Disease Control (CDC). Viral Hepatitis B Fact Sheet. Bethesda, MD: CDC, 2002.
7. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-1956.
8. Wincott F, DiRenzo A, Shaffer C, Grimm S, Tracz D, Workman C, et al. Synthesis, deprotection, analysis and purification of RNA and ribozymes. Nucleic Acids Res 1995;23:2677-2684.
9. Buckwold VE, Xu Z, Chen M, Yen TS, Ou JH. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 1996;70:5845-5851.
10. Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 1999;6:1258-1266.
11. Yang PL, Althage A, Chung J, Chisari FV. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci U S A 2002;99:13825-13830.
12. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 2001;20:6877-6888.
13. Chiu YL, Rana TM. siRNA function in RNAi: a chemical modification analysis. RNA 2003;9:1034-1048.
14. Parrish S, Fleenor J, Xu S, Mello C, Fire A. Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference. Mol Cell 2000;6:1077-1087.
15. Capodici J, Kariko K, Weissman D. Inhibition of HIV-1 Infection by small interfering RNA-mediated RNA interference. J Immunol 2002;169:5196-5201.
16. Layzer JM, McCaffrey AP, Tanner AK, Huang Z, Kay MA, Sullenger BA. In vivo activity of nuclease-resistant siRNAs. RNA 2004;10:766-771.
17. Giladi H, Ketzinel-Gilad M, Rivkin L, Felig Y, Nussbaum O, Galun E. Small interfering RNA inhibits hepatitis B virus replication in mice. Mol Ther 2003;8:769-776.
18. Klein C, Bock CT, Wedemeyer H, Wustefeld T, Locarnini S, Dienes HP, et al. Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA. Gastroenterology 2003;125:9-18.
19. McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H, et al. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 2003;21:639-644.
20. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004;432:173-178.